While BAFF binding to BAFF-R is dispensable for peritoneal CLL cell survival, it is necessary to activate a tumor-promoting gene program, potentially linked to CLL initiation and progression. The gene discussed is TNFRSF13C; the disease is B-cell chronic lymphocytic leukemia.